Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs.

Détails

ID Serval
serval:BIB_058287FB6D38
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs.
Périodique
Toxicology in vitro
Auteur⸱e⸱s
van Leeuwen J.S., Unlü B., Vermeulen N.P., Vos J.C.
ISSN
1879-3177 (Electronic)
ISSN-L
0887-2333
Statut éditorial
Publié
Date de publication
03/2012
Peer-reviewed
Oui
Volume
26
Numéro
2
Pages
197-205
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of pain and inflammation. However, this group of drugs is associated with serious adverse drug reactions. Previously, we studied the mechanisms underlying toxicity of the NSAID diclofenac using Saccharomycescerevisiae as model system. We identified the involvement of several mitochondrial proteins, a transporter and cytochrome P450 activity in diclofenac toxicity. In this study, we investigated if these processes are also involved in the toxicity of other NSAIDs. We divided the NSAIDs into three classes based on their toxicity mechanisms. Class I consists of diclofenac, indomethacin and ketoprofen. Mitochondrial respiration and reactive oxygen species (ROS) play a major role in the toxicity of this class. Metabolism by cytochrome P450s further increases their toxicity, while ABC-transporters decrease the toxicity. Mitochondria and oxidative metabolism also contribute to toxicity of class II drugs ibuprofen and naproxen, but another cellular target dominates their toxicity. Interestingly, ibuprofen was the only NSAID that was unable to induce upregulation of the multidrug resistance response. The class III NSAIDs sulindac, ketorolac and zomepirac were relatively non-toxic in yeast. In conclusion, we demonstrate the use of yeast to investigate the mechanisms underlying the toxicity of structurally related drugs.
Mots-clé
ATP-Binding Cassette Transporters/metabolism, Anti-Inflammatory Agents, Non-Steroidal/toxicity, Biological Transport, Active/drug effects, Cytochrome P-450 Enzyme System/metabolism, Diclofenac/toxicity, Electron Transport, Genes, MDR/drug effects, Ibuprofen/toxicity, Indomethacin/toxicity, Ketoprofen/toxicity, Ketorolac/toxicity, Mitochondria/drug effects, Mitochondria/physiology, Naproxen/toxicity, Reactive Oxygen Species/metabolism, Sulindac/toxicity, Tolmetin/analogs & derivatives, Tolmetin/toxicity, Yeasts/drug effects, Yeasts/growth & development, Yeasts/metabolism
Pubmed
Web of science
Création de la notice
22/01/2019 16:11
Dernière modification de la notice
21/08/2019 5:33
Données d'usage